Oak Street Health (OSH) Gets a Hold Rating from UBS

In a report released today, Andrew Mok CFA from UBS maintained a Hold rating on Oak Street Health (OSHResearch Report), with a price target of $28.00. The company’s shares closed last Wednesday at $29.50.

According to, CFA is a 3-star analyst with an average return of 5.7% and a 66.7% success rate. CFA covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, Universal Health, and Tenet Healthcare.

Currently, the analyst consensus on Oak Street Health is a Moderate Buy with an average price target of $28.30.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $65.22 and a one-year low of $13.29. Currently, Oak Street Health has an average volume of 1.8M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Oak Street Health Inc is a fast-growing network of value-based, primary care centers for adults on Medicare. The company operates an healthcare model focused on quality of care over volume of services, and assumes the full financial risk of its patients. Oak Street Health operates more than 50 centers across Illinois, Michigan, Indiana, Pennsylvania, Ohio, Rhode Island, North Carolina and Tennessee, with plans to continue its geographic expansion, including into Texas and New York.

Read More on OSH:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More